<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>bis620</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">bis620</h1>



<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(bis620<span class="fl">.2022</span>)</span></code></pre></div>
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>This vignette aims to illustrate the application of “bis620.2022”
package on the research analysis of treatment methods in the form of
two-arm clinical trials.</p>
<p>For demonstration, we will use the dataset <strong>A Phase 3
Randomized Trial of Chemotherapy With or Without Panitumumab in Patients
With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and
Neck (SCCHN)</strong> and examine the following research questions:</p>
<ul>
<li>To what extent does panitumumab perform on patients with the head
and neck cancer?
<ul>
<li>How do different groups (based on age, sex, ethnicity, HPV, ECOG
status, and cancer type including diagnosis stage) of patients respond
to panitumumab?</li>
<li>What is the distribution of best outcomes in terms of progressive
disease, stable disease, partial response and complete response in
different diagnosis types faceted by study arms?</li>
<li>Based on the actual treatment, what are the adverse events
associated and the distributions of severity levels accordingly?</li>
</ul></li>
</ul>
<p>Our hypothesis is that:</p>
<p><span class="math inline">\(H_{0}\)</span>: Panitumumab does not have
effect on the participants with the head and neck cancer in terms of the
death outcome and adverse events distribution.</p>
<p><span class="math inline">\(H_{1}\)</span>: Panitumumab has an effect
on the participants with the head and neck cancer in terms of the death
outcome and adverse events distribution.</p>
<p>Reference:</p>
<p><em>Amgen. (2018). A Phase 3 Randomized Trial of Chemotherapy With or
Without Panitumumab in Patients With Metastatic and/or Recurrent
Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Data set]. Project
Data Sphere. <a href="https://doi.org/10.34949/3EAJ-MD88">Study
Link</a></em></p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; load full_data table</span></span>
<span id="cb2-2"><a href="#cb2-2" aria-hidden="true" tabindex="-1"></a><span class="fu">data</span>(<span class="st">&quot;full_data&quot;</span>)</span>
<span id="cb2-3"><a href="#cb2-3" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb2-4"><a href="#cb2-4" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; a brief overview of the first patient from the demo dataset</span></span>
<span id="cb2-5"><a href="#cb2-5" aria-hidden="true" tabindex="-1"></a>full_data[<span class="dv">1</span>, ] <span class="sc">%&gt;%</span> <span class="fu">kable</span>()</span></code></pre></div>
<table>
<colgroup>
<col width="5%" />
<col width="2%" />
<col width="3%" />
<col width="12%" />
<col width="6%" />
<col width="5%" />
<col width="8%" />
<col width="5%" />
<col width="2%" />
<col width="6%" />
<col width="9%" />
<col width="3%" />
<col width="4%" />
<col width="7%" />
<col width="4%" />
<col width="7%" />
<col width="5%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">SUBJID</th>
<th align="right">AGE</th>
<th align="left">SEX</th>
<th align="left">ATRT</th>
<th align="left">B_ECOG</th>
<th align="left">DIAGTYPE</th>
<th align="left">DIAGSTAG</th>
<th align="left">DSTATUS</th>
<th align="left">HPV</th>
<th align="left">AETERM</th>
<th align="left">RACE</th>
<th align="right">DTHDY</th>
<th align="right">DOSREFDY</th>
<th align="left">RSRESP</th>
<th align="left">RSCONFYN</th>
<th align="left">TRTFREQ</th>
<th align="left">DEATH_FLAG</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">221101001</td>
<td align="right">55</td>
<td align="left">Female</td>
<td align="left">panit. plus chemotherapy</td>
<td align="left">Fully active</td>
<td align="left">Oropharynx</td>
<td align="left">Stage IVa - IVb</td>
<td align="left">recurrent</td>
<td align="left"></td>
<td align="left">OBSTIPATION</td>
<td align="left">White or Caucasian</td>
<td align="right">985</td>
<td align="right">41</td>
<td align="left">Stable disease</td>
<td align="left"></td>
<td align="left">Every 3 weeks</td>
<td align="left">Expired</td>
</tr>
</tbody>
</table>
</div>
<div id="method" class="section level2">
<h2>Method</h2>
<p>In order to delve into the research questions, we plan to divide the
research into two sections. The first section is to investigate the
distribution of the baseline characteristics of the patients including
age, sex, the primary tumor diagnosis including disease stage, the HPV
status, and the baseline ECOG performance status(the scale to access
one’s disease progression). Secondly, after acquiring a comprehensive
understanding of the baseline features of these participants, we will
analyze the efficacy of Panitumumab by comparing the death rate of
patients categorized based on the selected baseline features and the
actual treatment. Furthermore, we will look into and compare the
distributions of best outcomes by diagnosis types and study arms.
Lastly, we will evaluate the adverse event distributions between
participants with and without the intake of Panitumumab.</p>
</div>
<div id="part-i-baseline-characteristics-of-patients" class="section level2">
<h2>Part I: Baseline Characteristics of Patients</h2>
<div id="utilizing-the-functions-including-plot_age-descriptive_var-and-get_diag-from-our-package-the-following-demonstrates-the-distribution-of-the-baseline-characteristics-of-the-patients-including-age-sex-ethnicity-hpv-ecog-status-and-cancer-type-including-diagnosis-stage." class="section level4">
<h4>Utilizing the functions including <em>plot_age</em>,
<em>descriptive_var</em>, and <em>get_diag</em> from our package, the
following demonstrates the distribution of the baseline characteristics
of the patients including age, sex, ethnicity, HPV, ECOG status, and
cancer type including diagnosis stage.</h4>
</div>
<div id="age-distribution-of-patients-by-study-arm" class="section level3">
<h3>1.1 Age Distribution of Patients by Study Arm</h3>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" aria-hidden="true" tabindex="-1"></a>bis620<span class="fl">.2022</span><span class="sc">::</span><span class="fu">plot_age</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;AGE&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="dv">10</span>)</span>
<span id="cb3-2"><a href="#cb3-2" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Warning: `stat(count)` was deprecated in ggplot2 3.4.0.</span></span>
<span id="cb3-3"><a href="#cb3-3" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ℹ Please use `after_stat(count)` instead.</span></span>
<span id="cb3-4"><a href="#cb3-4" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ℹ The deprecated feature was likely used in the bis620.2022 package.</span></span>
<span id="cb3-5"><a href="#cb3-5" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;   Please report the issue to the authors.</span></span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<p>Based on the bar chart above, the age distributions of the patients
divided by the actual treatment from this clinical trial was relatively
even. Patients with ages between 50-70 took up the majority of the two
groups. Notably, among the patients with chemotherapy and Panitumumab,
there are 140 patients with ages between 50-60 which was the most
significant age category compared to others in this study group.</p>
</div>
<div id="gender-distribution-of-patients-by-study-arm" class="section level3">
<h3>1.2 Gender Distribution of Patients by Study Arm</h3>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" aria-hidden="true" tabindex="-1"></a>bis620<span class="fl">.2022</span><span class="sc">::</span><span class="fu">descriptive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;SEX&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">1</span>]] <span class="sc">%&gt;%</span></span>
<span id="cb4-2"><a href="#cb4-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">kable</span>()</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">SEX</th>
<th align="left">ATRT</th>
<th align="right">n</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Female</td>
<td align="left">Chemotherapy</td>
<td align="right">32</td>
</tr>
<tr class="even">
<td align="left">Female</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">33</td>
</tr>
<tr class="odd">
<td align="left">Male</td>
<td align="left">Chemotherapy</td>
<td align="right">228</td>
</tr>
<tr class="even">
<td align="left">Male</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">227</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(bis620<span class="fl">.2022</span><span class="sc">::</span><span class="fu">descriptive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;SEX&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">2</span>]])</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<p>For both groups, males were the majority among all patients with the
number of over 200 while females were less than 50.</p>
</div>
<div id="ethnicity-distribution-of-patients-by-study-arm" class="section level3">
<h3>1.3 Ethnicity Distribution of Patients by Study Arm</h3>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" aria-hidden="true" tabindex="-1"></a><span class="fu">descriptive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;RACE&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">1</span>]] <span class="sc">%&gt;%</span></span>
<span id="cb6-2"><a href="#cb6-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">kable</span>()</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">RACE</th>
<th align="left">ATRT</th>
<th align="right">n</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Asian</td>
<td align="left">Chemotherapy</td>
<td align="right">26</td>
</tr>
<tr class="even">
<td align="left">Asian</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">22</td>
</tr>
<tr class="odd">
<td align="left">Black or African American</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">Hispanic or Latino</td>
<td align="left">Chemotherapy</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">Other</td>
<td align="left">Chemotherapy</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">Other</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">Unknown</td>
<td align="left">Chemotherapy</td>
<td align="right">2</td>
</tr>
<tr class="even">
<td align="left">White or Caucasian</td>
<td align="left">Chemotherapy</td>
<td align="right">230</td>
</tr>
<tr class="odd">
<td align="left">White or Caucasian</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">236</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(<span class="fu">descriptive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;RACE&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">2</span>]])</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<p>According to the chart above, the leading ethnicity from both actual
treatment with and without Panitumumab was “White or Caucasian”
accounting for over 200 patients separately. In addition, “Asian” was
the second ethnicity in the lead with approximately 25 patients in each
group. “Black or African American” was only present in the study group
of Panitumumab and chemotherapy with the count of 1 while “Hispanic or
Lanito” was only present in the study group of chemotherapy with the
count of 1.</p>
</div>
<div id="hpv-distribution-of-patients-by-study-arm" class="section level3">
<h3>1.4 HPV Distribution of Patients by Study Arm</h3>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" aria-hidden="true" tabindex="-1"></a><span class="fu">descriptive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;HPV&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">1</span>]] <span class="sc">%&gt;%</span></span>
<span id="cb8-2"><a href="#cb8-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">kable</span>()</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">HPV</th>
<th align="left">ATRT</th>
<th align="right">n</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Negative</td>
<td align="left">Chemotherapy</td>
<td align="right">130</td>
</tr>
<tr class="even">
<td align="left">Negative</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">140</td>
</tr>
<tr class="odd">
<td align="left">Positive</td>
<td align="left">Chemotherapy</td>
<td align="right">28</td>
</tr>
<tr class="even">
<td align="left">Positive</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">41</td>
</tr>
<tr class="odd">
<td align="left">Unknown</td>
<td align="left">Chemotherapy</td>
<td align="right">102</td>
</tr>
<tr class="even">
<td align="left">Unknown</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">79</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(<span class="fu">descriptive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;HPV&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">2</span>]])</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<p>Based on this chart, most patients were diagnosed as negative for the
two study groups. The number of both negative and positive patients from
the group with Panitumumab and chemotherapy were relatively more than
those from Chemotherapy only. Further interpretation is limited due to
102 “Unknown” for the chemotherapy-only group and 79 “Unknown” for the
Panitumumab and chemotherapy group.</p>
</div>
<div id="ecog-status-distribution-of-patients-by-study-arm" class="section level3">
<h3>1.5 ECOG Status Distribution of Patients by Study Arm</h3>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" aria-hidden="true" tabindex="-1"></a><span class="fu">descriptive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;B_ECOG&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">1</span>]] <span class="sc">%&gt;%</span></span>
<span id="cb10-2"><a href="#cb10-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">kable</span>()</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">B_ECOG</th>
<th align="left">ATRT</th>
<th align="right">n</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Fully active</td>
<td align="left">Chemotherapy</td>
<td align="right">80</td>
</tr>
<tr class="even">
<td align="left">Fully active</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">70</td>
</tr>
<tr class="odd">
<td align="left">In bed less than 50% of the time</td>
<td align="left">Chemotherapy</td>
<td align="right">4</td>
</tr>
<tr class="even">
<td align="left">In bed less than 50% of the time</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">Symptoms but ambulatory</td>
<td align="left">Chemotherapy</td>
<td align="right">176</td>
</tr>
<tr class="even">
<td align="left">Symptoms but ambulatory</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">188</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(<span class="fu">descriptive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;B_ECOG&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">2</span>]])</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<p>According to the illustrations above, most patients from both study
groups had “symptoms but ambulatory.” However, there were 188 patients
from the study group using Panitumumab and chemotherapy noted with
“symptoms but ambulatory” which was relatively more than those from the
chemotherapy-only group while there where 70 patients from the group
using Panitumumab and chemotherapy noted with “fully active” which was
relatively less than those from the chemotherapy-only group.</p>
</div>
<div id="diagnosis-withoutwith-diagnosis-stage-distribution-of-patients-by-study-arm" class="section level3">
<h3>1.6 Diagnosis without/with Diagnosis Stage Distribution of Patients
by Study Arm</h3>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb12-1"><a href="#cb12-1" aria-hidden="true" tabindex="-1"></a><span class="fu">get_diag</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DIAGTYPE&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">1</span>]] <span class="sc">%&gt;%</span></span>
<span id="cb12-2"><a href="#cb12-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">head</span>(<span class="dv">10</span>) <span class="sc">%&gt;%</span></span>
<span id="cb12-3"><a href="#cb12-3" aria-hidden="true" tabindex="-1"></a>  <span class="fu">kable</span>()<span class="co">#the first 10 rows of the counts of diagnosis types without</span></span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">DIAGTYPE</th>
<th align="left">ATRT</th>
<th align="right">n</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Hypopharynx</td>
<td align="left">Chemotherapy</td>
<td align="right">32</td>
</tr>
<tr class="even">
<td align="left">Hypopharynx</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">43</td>
</tr>
<tr class="odd">
<td align="left">Larynx</td>
<td align="left">Chemotherapy</td>
<td align="right">75</td>
</tr>
<tr class="even">
<td align="left">Larynx</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">82</td>
</tr>
<tr class="odd">
<td align="left">Oral Cavity</td>
<td align="left">Chemotherapy</td>
<td align="right">79</td>
</tr>
<tr class="even">
<td align="left">Oral Cavity</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">63</td>
</tr>
<tr class="odd">
<td align="left">Oropharynx</td>
<td align="left">Chemotherapy</td>
<td align="right">74</td>
</tr>
<tr class="even">
<td align="left">Oropharynx</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">72</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb13-1"><a href="#cb13-1" aria-hidden="true" tabindex="-1"></a><span class="co">#stages are shown below</span></span>
<span id="cb13-2"><a href="#cb13-2" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(<span class="fu">get_diag</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DIAGTYPE&quot;</span>, <span class="st">&quot;ATRT&quot;</span>)[[<span class="dv">2</span>]])</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<p>For both study groups, the distribution of Larynx and Oripharynx
patients were relatively even with the count close to 75. The number of
oral cavity patients from the chemotherapy only group was 79 that is 17
more than those from the Panitumumab and chemotherapy group. In
addition, there were relatively less patients diagnosed with
Hypopharynx, specifically 32 in the chemotherapy-only group and 43 in
the Panitumumab and chemotherapy group.</p>
<div class="sourceCode" id="cb14"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb14-1"><a href="#cb14-1" aria-hidden="true" tabindex="-1"></a><span class="fu">get_diag</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DIAGTYPE&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="st">&quot;DIAGSTAG&quot;</span>)[[<span class="dv">1</span>]] <span class="sc">%&gt;%</span></span>
<span id="cb14-2"><a href="#cb14-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">head</span>(<span class="dv">10</span>) <span class="sc">%&gt;%</span></span>
<span id="cb14-3"><a href="#cb14-3" aria-hidden="true" tabindex="-1"></a>  <span class="fu">kable</span>()<span class="co">#the first 10 rows of the counts of diagnosis types with stages</span></span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">DIAGTYPE</th>
<th align="left">DIAGSTAG</th>
<th align="left">ATRT</th>
<th align="right">n</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Hypopharynx</td>
<td align="left">Stage II</td>
<td align="left">Chemotherapy</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">Hypopharynx</td>
<td align="left">Stage II</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">Hypopharynx</td>
<td align="left">Stage III</td>
<td align="left">Chemotherapy</td>
<td align="right">6</td>
</tr>
<tr class="even">
<td align="left">Hypopharynx</td>
<td align="left">Stage III</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">11</td>
</tr>
<tr class="odd">
<td align="left">Hypopharynx</td>
<td align="left">Stage IVa - IVb</td>
<td align="left">Chemotherapy</td>
<td align="right">18</td>
</tr>
<tr class="even">
<td align="left">Hypopharynx</td>
<td align="left">Stage IVa - IVb</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">25</td>
</tr>
<tr class="odd">
<td align="left">Hypopharynx</td>
<td align="left">Stage IVc</td>
<td align="left">Chemotherapy</td>
<td align="right">6</td>
</tr>
<tr class="even">
<td align="left">Hypopharynx</td>
<td align="left">Stage IVc</td>
<td align="left">panit. plus chemotherapy</td>
<td align="right">5</td>
</tr>
<tr class="odd">
<td align="left">Hypopharynx</td>
<td align="left">Unknown</td>
<td align="left">Chemotherapy</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">Larynx</td>
<td align="left">Stage I</td>
<td align="left">Chemotherapy</td>
<td align="right">7</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb15"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb15-1"><a href="#cb15-1" aria-hidden="true" tabindex="-1"></a><span class="co">#are shown below</span></span>
<span id="cb15-2"><a href="#cb15-2" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(<span class="fu">get_diag</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DIAGTYPE&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="st">&quot;DIAGSTAG&quot;</span>)[[<span class="dv">2</span>]])</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<p>For each diagnosis type from both study groups, “Stage IVa-IVb” was
the dominant diagnosis stage compared to other stages with at least 7
more patients than the second leading diagnosis stage except for oral
cavity patients from the Panitumumab and chemotherapy group.
Specifically, there were 21 patients with “Stage II” and “Stage IVa-IVb”
separately and 15 patients with “Stage III.” One patient with
unavailable diagnosis stage information was present in each of the three
populations: oral cavity patients from the chemotherapy-only group,
hypopharynx patients from the chemotherapy-only group, and oral cavity
patients from the Panitumumab and Chemotherapy group.</p>
</div>
</div>
<div id="part-ii-death-outcome-analysis" class="section level2">
<h2>Part II: Death Outcome Analysis</h2>
<div id="utilizing-the-functions-including-prognostic_var-and-predictive_var-from-our-package-the-following-illustrates-the-analysis-and-comparison-of-the-death-rates-of-patients-categorized-based-on-the-selected-baseline-features-and-the-actual-treatment-via-logistic-regression-model-in-order-to-investigate-the-efficacy-of-panitumumab-on-head-and-neck-cancer-patients." class="section level4">
<h4>Utilizing the functions including <em>prognostic_var</em> and
<em>predictive_var</em> from our package, the following illustrates the
analysis and comparison of the death rates of patients categorized based
on the selected baseline features and the actual treatment via logistic
regression model in order to investigate the efficacy of Panitumumab on
head and neck cancer patients.</h4>
</div>
<div id="first-of-all-we-have-run-the-prognostic_var-function-to-test-whether-diagnosis-type-and-ecog-status-the-selected-two-baseline-variables-most-associated-with-well-being-are-prognostic-with-regard-to-the-death-outcome-in-the-control-group-or-not." class="section level4">
<h4>First of all, we have run the <em>prognostic_var</em> function to
test whether diagnosis type and ECOG status, the selected two baseline
variables most associated with well being, are prognostic with regard to
the death outcome in the control group or not.</h4>
</div>
<div id="prognostic-test-on-diagnosis-type-and-death-outcome-in-the-control-group" class="section level3">
<h3>2.1 Prognostic test on Diagnosis Type and Death Outcome in the
Control Group</h3>
<div class="sourceCode" id="cb16"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb16-1"><a href="#cb16-1" aria-hidden="true" tabindex="-1"></a>l1 <span class="ot">&lt;-</span> <span class="fu">prognostic_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="st">&quot;Chemotherapy&quot;</span>,</span>
<span id="cb16-2"><a href="#cb16-2" aria-hidden="true" tabindex="-1"></a>                     <span class="st">&quot;DEATH_FLAG&quot;</span>, <span class="st">&quot;DIAGTYPE&quot;</span>)</span>
<span id="cb16-3"><a href="#cb16-3" aria-hidden="true" tabindex="-1"></a>var_coef <span class="ot">&lt;-</span> l1<span class="sc">$</span>coefficients</span>
<span id="cb16-4"><a href="#cb16-4" aria-hidden="true" tabindex="-1"></a>p_values <span class="ot">&lt;-</span> <span class="fu">summary</span>(l1)<span class="sc">$</span>coefficients[, <span class="st">&quot;Pr(&gt;|z|)&quot;</span>]</span>
<span id="cb16-5"><a href="#cb16-5" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb16-6"><a href="#cb16-6" aria-hidden="true" tabindex="-1"></a><span class="fu">as.data.frame</span>(<span class="fu">cbind</span>(var_coef, p_values)) <span class="sc">%&gt;%</span> <span class="fu">kable</span>()</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left"></th>
<th align="right">var_coef</th>
<th align="right">p_values</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">(Intercept)</td>
<td align="right">1.0986123</td>
<td align="right">0.0071229</td>
</tr>
<tr class="even">
<td align="left">var_vectorLarynx</td>
<td align="right">0.2876821</td>
<td align="right">0.5650448</td>
</tr>
<tr class="odd">
<td align="left">var_vectorOral Cavity</td>
<td align="right">0.0512933</td>
<td align="right">0.9159049</td>
</tr>
<tr class="even">
<td align="left">var_vectorOropharynx</td>
<td align="right">0.3566749</td>
<td align="right">0.4797827</td>
</tr>
</tbody>
</table>
<p>According to the P-value, 0.57 for larynx patients, 0.92 for oral
cavity patients, and 0.48 for oropharynx patients, it is concluded that
diagnosis type is not prognostic in terms of the death outcomes from the
chemotherapy-only group.</p>
</div>
<div id="prognostic-test-on-ecog-and-death-outcome-in-the-control-group" class="section level3">
<h3>2.2 Prognostic test on ECOG and Death Outcome in the Control
Group</h3>
<div class="sourceCode" id="cb17"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb17-1"><a href="#cb17-1" aria-hidden="true" tabindex="-1"></a>l2 <span class="ot">&lt;-</span> <span class="fu">prognostic_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="st">&quot;Chemotherapy&quot;</span>,</span>
<span id="cb17-2"><a href="#cb17-2" aria-hidden="true" tabindex="-1"></a>                     <span class="st">&quot;DEATH_FLAG&quot;</span>, <span class="st">&quot;B_ECOG&quot;</span>)</span>
<span id="cb17-3"><a href="#cb17-3" aria-hidden="true" tabindex="-1"></a>var_coef <span class="ot">&lt;-</span> l2<span class="sc">$</span>coef</span>
<span id="cb17-4"><a href="#cb17-4" aria-hidden="true" tabindex="-1"></a>p_values <span class="ot">&lt;-</span> <span class="fu">summary</span>(l2)<span class="sc">$</span>coefficients[, <span class="st">&quot;Pr(&gt;|z|)&quot;</span>]</span>
<span id="cb17-5"><a href="#cb17-5" aria-hidden="true" tabindex="-1"></a><span class="fu">as.data.frame</span>(<span class="fu">cbind</span>(var_coef, p_values)) <span class="sc">%&gt;%</span> <span class="fu">kable</span>()</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left"></th>
<th align="right">var_coef</th>
<th align="right">p_values</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">(Intercept)</td>
<td align="right">0.9075571</td>
<td align="right">0.0002389</td>
</tr>
<tr class="even">
<td align="left">var_vectorIn bed less than 50% of the time</td>
<td align="right">14.6585112</td>
<td align="right">0.9839288</td>
</tr>
<tr class="odd">
<td align="left">var_vectorSymptoms but ambulatory</td>
<td align="right">0.5587800</td>
<td align="right">0.0747383</td>
</tr>
</tbody>
</table>
<p>Based on the p-values returned, 0.98 for the status “In bed less than
50% of the time” and 0.07 for “Symptoms but ambulatory”, which are both
greater than 0.05. It is seen that ECOG status, as the scale to access
the disease progression is not prognostic to the death outcomes from the
control group.</p>
<div id="on-the-other-hand-we-have-applied-the-function-predictive_var-using-the-logistic-regression-model-and-included-the-six-baseline-features-accessed-in-part-1-including-age-gender-ethnicity-hpv-status-ecog-status-and-diagnosis-type-to-not-only-further-investigate-the-effect-of-panitumumab-on-patients-but-also-to-test-whether-these-features-are-predictive-in-terms-of-the-death-outcomes-from-two-study-groups-considering-the-interaction-between-these-features-and-panitumumab." class="section level4">
<h4>On the other hand, we have applied the function
<em>predictive_var</em> using the logistic regression model and included
the six baseline features accessed in part 1 including age, gender,
ethnicity, HPV status, ECOG status, and diagnosis type to not only
further investigate the effect of Panitumumab on patients but also to
test whether these features are predictive in terms of the death
outcomes from two study groups considering the interaction between these
features and Panitumumab.</h4>
</div>
</div>
<div id="predictivity-test-on-gender-actual-treatment-and-death-outcome" class="section level3">
<h3>2.3 Predictivity test on Gender, Actual Treatment and Death
Outcome</h3>
<div class="sourceCode" id="cb18"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb18-1"><a href="#cb18-1" aria-hidden="true" tabindex="-1"></a>l3 <span class="ot">&lt;-</span> <span class="fu">predictive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DEATH_FLAG&quot;</span>, <span class="st">&quot;ATRT&quot;</span>,</span>
<span id="cb18-2"><a href="#cb18-2" aria-hidden="true" tabindex="-1"></a>                       <span class="at">var_col =</span> <span class="st">&quot;SEX&quot;</span>, <span class="at">interaction =</span> <span class="cn">TRUE</span>)</span>
<span id="cb18-3"><a href="#cb18-3" aria-hidden="true" tabindex="-1"></a>var_coef <span class="ot">&lt;-</span> l3<span class="sc">$</span>coefficients</span>
<span id="cb18-4"><a href="#cb18-4" aria-hidden="true" tabindex="-1"></a>p_values <span class="ot">&lt;-</span> <span class="fu">summary</span>(l3)<span class="sc">$</span>coefficients[, <span class="st">&quot;Pr(&gt;|z|)&quot;</span>]</span>
<span id="cb18-5"><a href="#cb18-5" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb18-6"><a href="#cb18-6" aria-hidden="true" tabindex="-1"></a><span class="fu">as.data.frame</span>(<span class="fu">cbind</span>(var_coef, p_values)) <span class="sc">%&gt;%</span> <span class="fu">kable</span>()</span></code></pre></div>
<table>
<colgroup>
<col width="75%" />
<col width="13%" />
<col width="11%" />
</colgroup>
<thead>
<tr class="header">
<th align="left"></th>
<th align="right">var_coef</th>
<th align="right">p_values</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">(Intercept)</td>
<td align="right">0.6466272</td>
<td align="right">0.0823270</td>
</tr>
<tr class="even">
<td align="left">var_vectorMale</td>
<td align="right">0.7561965</td>
<td align="right">0.0636231</td>
</tr>
<tr class="odd">
<td align="left">as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">0.8574502</td>
<td align="right">0.1427267</td>
</tr>
<tr class="even">
<td align="left">var_vectorMale:as.factor(treat_vector)panit. plus
chemotherapy</td>
<td align="right">-0.5581266</td>
<td align="right">0.3797136</td>
</tr>
</tbody>
</table>
<p>According to the summary above, the p-value for gender is 0.06 and
0.14 for the actual treatment, implying the insignificance of gender and
Panitumumab as individual factor on the death outcome performance.
Hence, gender is not predictive with regards to the use of Panitumumab
and the death outcome.</p>
</div>
<div id="predictivity-test-on-age-actual-treatment-and-death-outcome" class="section level3">
<h3>2.4 Predictivity test on Age, Actual Treatment and Death
Outcome</h3>
<div class="sourceCode" id="cb19"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb19-1"><a href="#cb19-1" aria-hidden="true" tabindex="-1"></a>l4 <span class="ot">&lt;-</span> <span class="fu">predictive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DEATH_FLAG&quot;</span>, <span class="st">&quot;ATRT&quot;</span>,</span>
<span id="cb19-2"><a href="#cb19-2" aria-hidden="true" tabindex="-1"></a>                       <span class="at">var_col =</span> <span class="st">&quot;AGE&quot;</span>, <span class="at">interaction =</span> <span class="cn">TRUE</span>)</span>
<span id="cb19-3"><a href="#cb19-3" aria-hidden="true" tabindex="-1"></a>var_coef <span class="ot">&lt;-</span> l4<span class="sc">$</span>coefficients</span>
<span id="cb19-4"><a href="#cb19-4" aria-hidden="true" tabindex="-1"></a>p_values <span class="ot">&lt;-</span> <span class="fu">summary</span>(l4)<span class="sc">$</span>coefficients[, <span class="st">&quot;Pr(&gt;|z|)&quot;</span>]</span>
<span id="cb19-5"><a href="#cb19-5" aria-hidden="true" tabindex="-1"></a><span class="fu">as.data.frame</span>(<span class="fu">cbind</span>(var_coef, p_values)) <span class="sc">%&gt;%</span> <span class="fu">kable</span>()</span></code></pre></div>
<table>
<colgroup>
<col width="73%" />
<col width="13%" />
<col width="12%" />
</colgroup>
<thead>
<tr class="header">
<th align="left"></th>
<th align="right">var_coef</th>
<th align="right">p_values</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">(Intercept)</td>
<td align="right">-0.0852913</td>
<td align="right">0.9399639</td>
</tr>
<tr class="even">
<td align="left">var_vector</td>
<td align="right">0.0238621</td>
<td align="right">0.2226866</td>
</tr>
<tr class="odd">
<td align="left">as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">1.4084475</td>
<td align="right">0.3983492</td>
</tr>
<tr class="even">
<td align="left">var_vector:as.factor(treat_vector)panit. plus
chemotherapy</td>
<td align="right">-0.0177072</td>
<td align="right">0.5396512</td>
</tr>
</tbody>
</table>
<p>Based on the p-values, 0.22 for age and 0.40 for the actual treatment
that are greater than 0.05, the effect of age and the actual treatment
on death outcomes is not significant. Therefore, predictivity of age on
treatment and death outcomes is not proved.</p>
</div>
<div id="predictivity-test-on-ethnicity-actual-treatment-and-death-outcome" class="section level3">
<h3>2.5 Predictivity test on Ethnicity, Actual Treatment and Death
Outcome</h3>
<div class="sourceCode" id="cb20"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb20-1"><a href="#cb20-1" aria-hidden="true" tabindex="-1"></a>l5 <span class="ot">&lt;-</span> <span class="fu">predictive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DEATH_FLAG&quot;</span>, <span class="st">&quot;ATRT&quot;</span>,</span>
<span id="cb20-2"><a href="#cb20-2" aria-hidden="true" tabindex="-1"></a>                       <span class="at">var_col =</span> <span class="st">&quot;RACE&quot;</span>, <span class="at">interaction =</span> <span class="cn">TRUE</span>)</span>
<span id="cb20-3"><a href="#cb20-3" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb20-4"><a href="#cb20-4" aria-hidden="true" tabindex="-1"></a>var_coef <span class="ot">&lt;-</span> l5<span class="sc">$</span>coefficients</span>
<span id="cb20-5"><a href="#cb20-5" aria-hidden="true" tabindex="-1"></a>p_values <span class="ot">&lt;-</span> <span class="fu">summary</span>(l5)<span class="sc">$</span>coefficients[, <span class="st">&quot;Pr(&gt;|z|)&quot;</span>]</span>
<span id="cb20-6"><a href="#cb20-6" aria-hidden="true" tabindex="-1"></a><span class="fu">as.data.frame</span>(<span class="fu">cbind</span>(var_coef, p_values)) <span class="sc">%&gt;%</span> <span class="fu">kable</span>()</span>
<span id="cb20-7"><a href="#cb20-7" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Warning in cbind(var_coef, p_values): number of rows of result is not a multiple</span></span>
<span id="cb20-8"><a href="#cb20-8" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; of vector length (arg 2)</span></span></code></pre></div>
<table>
<colgroup>
<col width="79%" />
<col width="11%" />
<col width="9%" />
</colgroup>
<thead>
<tr class="header">
<th align="left"></th>
<th align="right">var_coef</th>
<th align="right">p_values</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">(Intercept)</td>
<td align="right">0.9985288</td>
<td align="right">0.0239211</td>
</tr>
<tr class="even">
<td align="left">var_vectorBlack or African American</td>
<td align="right">-16.3282083</td>
<td align="right">0.9910487</td>
</tr>
<tr class="odd">
<td align="left">var_vectorHispanic or Latino</td>
<td align="right">14.5675394</td>
<td align="right">0.9920139</td>
</tr>
<tr class="even">
<td align="left">var_vectorOther</td>
<td align="right">14.5675394</td>
<td align="right">0.9920139</td>
</tr>
<tr class="odd">
<td align="left">var_vectorWhite or Caucasian</td>
<td align="right">0.3081479</td>
<td align="right">0.5125573</td>
</tr>
<tr class="even">
<td align="left">as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">-0.2363888</td>
<td align="right">0.7103073</td>
</tr>
<tr class="odd">
<td align="left">var_vectorBlack or African
American:as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">NA</td>
<td align="right">0.9999084</td>
</tr>
<tr class="even">
<td align="left">var_vectorHispanic or
Latino:as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">NA</td>
<td align="right">0.2743019</td>
</tr>
<tr class="odd">
<td align="left">var_vectorOther:as.factor(treat_vector)panit. plus
chemotherapy</td>
<td align="right">0.2363888</td>
<td align="right">0.0239211</td>
</tr>
<tr class="even">
<td align="left">var_vectorWhite or
Caucasian:as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">0.7464105</td>
<td align="right">0.9910487</td>
</tr>
</tbody>
</table>
<p>Based on the p-values that are no less that 0.50 for ethnicity types
and the actual treatment that are greater than 0.05, the impact of
ethnicity and the actual treatment on death outcomes is insignificant.
Therefore, ethinicity is not a predictive factor in terms of treatment
and death outcomes.</p>
</div>
<div id="predictivity-test-on-hpv-status-actual-treatment-and-death-outcome" class="section level3">
<h3>2.6 Predictivity test on HPV status, Actual Treatment and Death
Outcome</h3>
<div class="sourceCode" id="cb21"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb21-1"><a href="#cb21-1" aria-hidden="true" tabindex="-1"></a>l6 <span class="ot">&lt;-</span> <span class="fu">predictive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DEATH_FLAG&quot;</span>, <span class="st">&quot;ATRT&quot;</span>,</span>
<span id="cb21-2"><a href="#cb21-2" aria-hidden="true" tabindex="-1"></a>                       <span class="at">var_col =</span> <span class="st">&quot;HPV&quot;</span>, <span class="at">interaction =</span> <span class="cn">TRUE</span>)</span>
<span id="cb21-3"><a href="#cb21-3" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb21-4"><a href="#cb21-4" aria-hidden="true" tabindex="-1"></a>var_coef <span class="ot">&lt;-</span> l6<span class="sc">$</span>coefficients</span>
<span id="cb21-5"><a href="#cb21-5" aria-hidden="true" tabindex="-1"></a>p_values <span class="ot">&lt;-</span> <span class="fu">summary</span>(l6)<span class="sc">$</span>coefficients[, <span class="st">&quot;Pr(&gt;|z|)&quot;</span>]</span>
<span id="cb21-6"><a href="#cb21-6" aria-hidden="true" tabindex="-1"></a><span class="fu">as.data.frame</span>(<span class="fu">cbind</span>(var_coef, p_values)) <span class="sc">%&gt;%</span> <span class="fu">kable</span>()</span></code></pre></div>
<table>
<colgroup>
<col width="76%" />
<col width="12%" />
<col width="11%" />
</colgroup>
<thead>
<tr class="header">
<th align="left"></th>
<th align="right">var_coef</th>
<th align="right">p_values</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">(Intercept)</td>
<td align="right">1.5910888</td>
<td align="right">0.0000000</td>
</tr>
<tr class="even">
<td align="left">var_vectorPositive</td>
<td align="right">-0.0650325</td>
<td align="right">0.9052025</td>
</tr>
<tr class="odd">
<td align="left">as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">0.5291748</td>
<td align="right">0.1412347</td>
</tr>
<tr class="even">
<td align="left">var_vectorPositive:as.factor(treat_vector)panit. plus
chemotherapy</td>
<td align="right">-0.2916425</td>
<td align="right">0.6988019</td>
</tr>
</tbody>
</table>
<p>As the p-value for HPV status is 0.09 and 0.14 for the actual
treatment, it is concluded that these two factors individually are not
significant on the performance of death outcome. As a result, HPV status
is not applicable for a predictive factor in this scenario.</p>
</div>
<div id="predictivity-test-on-ecog-status-actual-treatment-and-death-outcome" class="section level3">
<h3>2.7 Predictivity test on ECOG Status, Actual Treatment and Death
Outcome</h3>
<div class="sourceCode" id="cb22"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb22-1"><a href="#cb22-1" aria-hidden="true" tabindex="-1"></a>l7 <span class="ot">&lt;-</span> <span class="fu">predictive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DEATH_FLAG&quot;</span>, <span class="st">&quot;ATRT&quot;</span>,</span>
<span id="cb22-2"><a href="#cb22-2" aria-hidden="true" tabindex="-1"></a>                       <span class="at">var_col =</span> <span class="st">&quot;B_ECOG&quot;</span>, <span class="at">interaction =</span> <span class="cn">TRUE</span>)</span>
<span id="cb22-3"><a href="#cb22-3" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb22-4"><a href="#cb22-4" aria-hidden="true" tabindex="-1"></a>var_coef <span class="ot">&lt;-</span> l7<span class="sc">$</span>coefficients</span>
<span id="cb22-5"><a href="#cb22-5" aria-hidden="true" tabindex="-1"></a>p_values <span class="ot">&lt;-</span> <span class="fu">summary</span>(l7)<span class="sc">$</span>coefficients[, <span class="st">&quot;Pr(&gt;|z|)&quot;</span>]</span>
<span id="cb22-6"><a href="#cb22-6" aria-hidden="true" tabindex="-1"></a><span class="fu">as.data.frame</span>(<span class="fu">cbind</span>(var_coef, p_values)) <span class="sc">%&gt;%</span> <span class="fu">kable</span>()</span></code></pre></div>
<table>
<colgroup>
<col width="81%" />
<col width="9%" />
<col width="8%" />
</colgroup>
<thead>
<tr class="header">
<th align="left"></th>
<th align="right">var_coef</th>
<th align="right">p_values</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">(Intercept)</td>
<td align="right">0.9075571</td>
<td align="right">0.0002389</td>
</tr>
<tr class="even">
<td align="left">var_vectorIn bed less than 50% of the time</td>
<td align="right">14.6585112</td>
<td align="right">0.9839288</td>
</tr>
<tr class="odd">
<td align="left">var_vectorSymptoms but ambulatory</td>
<td align="right">0.5587800</td>
<td align="right">0.0747383</td>
</tr>
<tr class="even">
<td align="left">as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">0.6679793</td>
<td align="right">0.0965776</td>
</tr>
<tr class="odd">
<td align="left">var_vectorIn bed less than 50% of the
time:as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">-0.6679793</td>
<td align="right">0.9995771</td>
</tr>
<tr class="even">
<td align="left">var_vectorSymptoms but
ambulatory:as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">-0.4327080</td>
<td align="right">0.3767617</td>
</tr>
</tbody>
</table>
<p>Based on the summary shown above, no p-values for the actual
treatment, the status of “In bed less than 50% of the time”, and
“Symptoms but ambulatory” are less than 0.07. Therefore, both ECOG
status and the actual treatment are insignificant factor in terms of the
death outcome of patients. Hence, ECOG status is not predictive with
regards to this clinical trail.</p>
</div>
<div id="predictivity-test-on-diagnosis-type-actual-treatment-and-death-outcome" class="section level3">
<h3>2.8 Predictivity test on Diagnosis Type, Actual Treatment and Death
Outcome</h3>
<div class="sourceCode" id="cb23"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb23-1"><a href="#cb23-1" aria-hidden="true" tabindex="-1"></a>l8 <span class="ot">&lt;-</span> <span class="fu">predictive_var</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;DEATH_FLAG&quot;</span>, <span class="st">&quot;ATRT&quot;</span>,</span>
<span id="cb23-2"><a href="#cb23-2" aria-hidden="true" tabindex="-1"></a>                       <span class="at">var_col =</span> <span class="st">&quot;DIAGTYPE&quot;</span>, <span class="at">interaction =</span> <span class="cn">TRUE</span>)</span>
<span id="cb23-3"><a href="#cb23-3" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb23-4"><a href="#cb23-4" aria-hidden="true" tabindex="-1"></a>var_coef <span class="ot">&lt;-</span> l8<span class="sc">$</span>coefficients</span>
<span id="cb23-5"><a href="#cb23-5" aria-hidden="true" tabindex="-1"></a>p_values <span class="ot">&lt;-</span> <span class="fu">summary</span>(l8)<span class="sc">$</span>coefficients[, <span class="st">&quot;Pr(&gt;|z|)&quot;</span>]</span>
<span id="cb23-6"><a href="#cb23-6" aria-hidden="true" tabindex="-1"></a><span class="fu">as.data.frame</span>(<span class="fu">cbind</span>(var_coef, p_values)) <span class="sc">%&gt;%</span> <span class="fu">kable</span>()</span></code></pre></div>
<table>
<colgroup>
<col width="76%" />
<col width="12%" />
<col width="10%" />
</colgroup>
<thead>
<tr class="header">
<th align="left"></th>
<th align="right">var_coef</th>
<th align="right">p_values</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">(Intercept)</td>
<td align="right">1.0986123</td>
<td align="right">0.0071229</td>
</tr>
<tr class="even">
<td align="left">var_vectorLarynx</td>
<td align="right">0.2876821</td>
<td align="right">0.5650448</td>
</tr>
<tr class="odd">
<td align="left">var_vectorOral Cavity</td>
<td align="right">0.0512933</td>
<td align="right">0.9159049</td>
</tr>
<tr class="even">
<td align="left">var_vectorOropharynx</td>
<td align="right">0.3566749</td>
<td align="right">0.4797827</td>
</tr>
<tr class="odd">
<td align="left">as.factor(treat_vector)panit. plus chemotherapy</td>
<td align="right">0.7205462</td>
<td align="right">0.2300188</td>
</tr>
<tr class="even">
<td align="left">var_vectorLarynx:as.factor(treat_vector)panit. plus
chemotherapy</td>
<td align="right">-0.3432519</td>
<td align="right">0.6408289</td>
</tr>
<tr class="odd">
<td align="left">var_vectorOral Cavity:as.factor(treat_vector)panit.
plus chemotherapy</td>
<td align="right">-0.5233781</td>
<td align="right">0.4707587</td>
</tr>
<tr class="even">
<td align="left">var_vectorOropharynx:as.factor(treat_vector)panit. plus
chemotherapy</td>
<td align="right">-0.3512841</td>
<td align="right">0.6401325</td>
</tr>
</tbody>
</table>
<p>According to the test result above, the p-values for the diagnosis
types and the actual treatment itself are all greater than at least 0.2,
which is significantly larger than 0.05. It could be told that diagnosis
type and the actual treatment individually have no significant impact on
the performance of death outcome. Therefore, diagnosis type is not
predictive with regards to the actual treatment and the death
outcome.</p>
</div>
</div>
<div id="part-iii-best-response-analysis-by-diagnosis-type-and-study-arm" class="section level2">
<h2>Part III: Best Response Analysis by Diagnosis Type and Study
Arm</h2>
<div class="sourceCode" id="cb24"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb24-1"><a href="#cb24-1" aria-hidden="true" tabindex="-1"></a><span class="fu">get_response</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="st">&quot;RSRESP&quot;</span>, <span class="st">&quot;RSCONFYN&quot;</span>,</span>
<span id="cb24-2"><a href="#cb24-2" aria-hidden="true" tabindex="-1"></a>             <span class="st">&quot;DIAGTYPE&quot;</span>)[[<span class="dv">1</span>]] <span class="sc">%&gt;%</span></span>
<span id="cb24-3"><a href="#cb24-3" aria-hidden="true" tabindex="-1"></a>   <span class="fu">kable</span>()</span></code></pre></div>
<table>
<colgroup>
<col width="17%" />
<col width="26%" />
<col width="19%" />
<col width="36%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">DIAGTYPE</th>
<th align="left">RSRESP</th>
<th align="right">Chemotherapy</th>
<th align="right">panit. plus chemotherapy</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Hypopharynx</td>
<td align="left">Partial response</td>
<td align="right">7</td>
<td align="right">11</td>
</tr>
<tr class="even">
<td align="left">Larynx</td>
<td align="left">Complete response</td>
<td align="right">3</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">Larynx</td>
<td align="left">Partial response</td>
<td align="right">14</td>
<td align="right">30</td>
</tr>
<tr class="even">
<td align="left">Oral Cavity</td>
<td align="left">Complete response</td>
<td align="right">1</td>
<td align="right">6</td>
</tr>
<tr class="odd">
<td align="left">Oral Cavity</td>
<td align="left">Partial response</td>
<td align="right">14</td>
<td align="right">12</td>
</tr>
<tr class="even">
<td align="left">Oropharynx</td>
<td align="left">Complete response</td>
<td align="right">3</td>
<td align="right">NA</td>
</tr>
<tr class="odd">
<td align="left">Oropharynx</td>
<td align="left">Partial response</td>
<td align="right">16</td>
<td align="right">18</td>
</tr>
<tr class="even">
<td align="left">Hypopharynx</td>
<td align="left">Complete response</td>
<td align="right">NA</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb25"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb25-1"><a href="#cb25-1" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb25-2"><a href="#cb25-2" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(<span class="fu">get_response</span>(full_data, <span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="st">&quot;RSRESP&quot;</span>, <span class="st">&quot;RSCONFYN&quot;</span>,</span>
<span id="cb25-3"><a href="#cb25-3" aria-hidden="true" tabindex="-1"></a>                   <span class="st">&quot;DIAGTYPE&quot;</span>)[[<span class="dv">2</span>]])</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<p>The 8 bar charts above illustrate the distribution of best outcomes,
complete response and partial response, among patients with different
diagnosis types and study arms. Based on these charts, partial response
take up the majority of the total numbers. Notably, there was no patient
with complete response in the groups with hypopharnyx and chemotherapy,
and oropharynx and Panitumumab plus chemotherapy. On the other hand, for
larynx, there were more patients with partial response in the
Panitumumab and chemotherapy group than the chemotherapy-only group.
Moreover, for oral cavity, there were more patients complete response in
the Panitumumab and chemotherapy group than the chemotherapy-only
group.</p>
</div>
<div id="part-iv-adverse-events-analysis" class="section level2">
<h2>Part IV: Adverse Events Analysis</h2>
<div id="with-the-application-the-function-get_ae-from-our-package-the-following-showcases-the-examination-of-the-adverse-events-of-patients-categorized-by-the-study-arm-in-order-to-look-into-the-effect-of-panitumumab-on-the-clinical-trail-participants-in-a-more-comprehensive-approach." class="section level4">
<h4>With the application the function <em>get_ae</em> from our package,
the following showcases the examination of the adverse events of
patients categorized by the study arm in order to look into the effect
of Panitumumab on the clinical trail participants in a more
comprehensive approach.</h4>
<div class="sourceCode" id="cb26"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb26-1"><a href="#cb26-1" aria-hidden="true" tabindex="-1"></a><span class="fu">get_ae</span>(full_data, <span class="st">&quot;AETERM&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="dv">20</span>)[[<span class="dv">1</span>]] <span class="sc">%&gt;%</span></span>
<span id="cb26-2"><a href="#cb26-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">kable</span>()</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">AETERM</th>
<th align="right">Chemotherapy</th>
<th align="right">panit. plus chemotherapy</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">NAUSEA</td>
<td align="right">461</td>
<td align="right">525</td>
</tr>
<tr class="even">
<td align="left">NEUTROPENIA</td>
<td align="right">434</td>
<td align="right">532</td>
</tr>
<tr class="odd">
<td align="left">VOMITING</td>
<td align="right">258</td>
<td align="right">370</td>
</tr>
<tr class="even">
<td align="left">ANEMIA</td>
<td align="right">248</td>
<td align="right">377</td>
</tr>
<tr class="odd">
<td align="left">FATIGUE</td>
<td align="right">186</td>
<td align="right">262</td>
</tr>
<tr class="even">
<td align="left">ANOREXIA</td>
<td align="right">179</td>
<td align="right">185</td>
</tr>
<tr class="odd">
<td align="left">MUCOSITIS</td>
<td align="right">155</td>
<td align="right">160</td>
</tr>
<tr class="even">
<td align="left">STOMATITIS</td>
<td align="right">150</td>
<td align="right">NA</td>
</tr>
<tr class="odd">
<td align="left">CONSTIPATION</td>
<td align="right">137</td>
<td align="right">245</td>
</tr>
<tr class="even">
<td align="left">HYPOMAGNESEMIA</td>
<td align="right">137</td>
<td align="right">307</td>
</tr>
<tr class="odd">
<td align="left">WEIGHT LOSS</td>
<td align="right">121</td>
<td align="right">201</td>
</tr>
<tr class="even">
<td align="left">ANAEMIA</td>
<td align="right">102</td>
<td align="right">113</td>
</tr>
<tr class="odd">
<td align="left">DIARRHEA</td>
<td align="right">96</td>
<td align="right">206</td>
</tr>
<tr class="even">
<td align="left">FEVER</td>
<td align="right">93</td>
<td align="right">155</td>
</tr>
<tr class="odd">
<td align="left">LEUCOPENIA</td>
<td align="right">90</td>
<td align="right">137</td>
</tr>
<tr class="even">
<td align="left">THROMBOCYTOPENIA</td>
<td align="right">90</td>
<td align="right">NA</td>
</tr>
<tr class="odd">
<td align="left">NEUROPATHY</td>
<td align="right">81</td>
<td align="right">NA</td>
</tr>
<tr class="even">
<td align="left">ASTHENIA</td>
<td align="right">80</td>
<td align="right">128</td>
</tr>
<tr class="odd">
<td align="left">HEADACHE</td>
<td align="right">69</td>
<td align="right">NA</td>
</tr>
<tr class="even">
<td align="left">TROMBOCYTOPENIA</td>
<td align="right">68</td>
<td align="right">NA</td>
</tr>
<tr class="odd">
<td align="left">SKIN RASH</td>
<td align="right">NA</td>
<td align="right">204</td>
</tr>
<tr class="even">
<td align="left">RASH</td>
<td align="right">NA</td>
<td align="right">183</td>
</tr>
<tr class="odd">
<td align="left">ALOPECIA</td>
<td align="right">NA</td>
<td align="right">163</td>
</tr>
<tr class="even">
<td align="left">COUGH</td>
<td align="right">NA</td>
<td align="right">155</td>
</tr>
<tr class="odd">
<td align="left">DRY SKIN</td>
<td align="right">NA</td>
<td align="right">124</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb27"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb27-1"><a href="#cb27-1" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(<span class="fu">get_ae</span>(full_data, <span class="st">&quot;AETERM&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="dv">20</span>)[[<span class="dv">2</span>]])</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" />
The table and bar chart above record the top 20 adverse events
identified in patients from the two study groups. Specifically, nausea,
neutropenia, vomiting, anemia, fatigue, and hypomagnesemia by the
descending order were the 6 most frequent adverse events for both study
groups. Stomatitis, thrombocytopenia, neuropathy, headache
trombocytopenia were shown in the top 20 adverse events only among the
patients from the chemotherapy-only group. Likewise, skin rash, rash,
dry skin, alopecia, and cough were the unique top 20 adverse events
recorded among the participants from the Panitumumab and chemotherapy
group.</p>
<p>It is worth noticing that comparing the count of adverse events from
top 1 to top 20 between the two groups with different study arm, the
number of the adverse events from the Panitumumab and chemotherapy
groups were greater than the ones with same ranking form the other
groups. This finding has led to two potential intrepretations. First,
Panitumumab tends to relate to the increase in the total number of
adverse events among patients. Second, Panitumumab is likely to be
associated with the intensity of the leading adverse events comparing to
those with chemotherapy only.</p>
</div>
</div>
<div id="discussion" class="section level2">
<h2>Discussion</h2>
<p>According to the summary of baseline features of all participants in
this clinial trial from Part I in terms of age, sex, ethnicity, hpv
status, ECOG status, and diagnosis types, the participants were
separated relatively evenly into one study group with chemotherapy only
and the other with Panitumumab and chemotherapy, that assists the
comparability of further analysis results of the death outcome
performance and adverse events between the two study groups.</p>
<p>In addition, the prognostic tests show that ECOG status and diagnosis
types, the two factors most relative to the well being of the patients
before recieving treatment, are not prognostic indicator for the death
outcomes in the control group. Nevertheless, after conducting the tests
for predictive factors considering all the six selected baseline
features, it is elucidated that none of the baseline features are
moderators regarding the interaction between the death outcomes of
patients and the actual treatment. Moreover, the p-values of the actual
treatment itself in the tests has indicated its insignificant impact on
the performance of the death outcome of the participants. However, the
results can be potentially affected by the number of patients with
unavailable information for baseline features, indicated by “unknown” or
“other” in the dataset. For example, there were a fair number of
participants identified as “unknown” for HPV status taking up
approximately one-third of the population from each group. On the other
hand, the best outcome distributions by diagnosis types and study arm
are moderately even with partial response taking the lead. Nevertheless,
no notable difference regarding the best outcome distribution is noted
compared to the patients from different study arm groups.</p>
<p>Lastly, comparing the adverse events between the two groups, there
are two ways of potential interpretation that requires further
verification from future researchers. One way to understand the larger
number of top 20 adverse events in the group with Panitumumab and
chemotherapy than the control group is that Panitumumab is associated
with the increase of adverse events across the scope for patients with
head and neck cancer. The other way of intrepretation is that
Panitumumab is likely to lead to the intensification of the common
adverse events shared with the control group.</p>
</div>
<div id="conclusion" class="section level2">
<h2>Conclusion</h2>
<p>In conclusion, after the exploration of baseline features of the head
and neck cancer participants, logistic regression tests to testify
predictive and prognostic features and adverse events analysis, we
reject the <span class="math inline">\(H_{1}\)</span> hypothesis that
Panitumumab has an effect on the participants with the head and neck
cancer in terms of the death outcome and adverse events distribution. In
addition, we conclude with the <span class="math inline">\(H_{0}\)</span> hypothesis that Panitumumab does
not have effect on the participants with the head and neck cancer in
terms of the death outcome and adverse events distribution. We call upon
the society’s attention for the population with head and neck cancers
and encourage researchers to delve into effective treatments for this
population.</p>
<p>On the other hand, this research serves as the demonstration
regarding the application of our “bis620.2022” package on scientific
researches on medical treatments in the form of two-arm clinical trials.
Specifically, functions including <em>plot_age</em>,
<em>descriptive_var</em>, and <em>get_diag</em> are used for baseline
features summary of participants in this clinical trial. Functions such
as <em>prognostic_var</em> and <em>predictive_var</em> are utilied for
testifying prognostic features and predictive features in terms of the
performance of death outcome among the patients and assessing the impact
of the actual treatment simultaneously. Lastly, the function
<em>get_ae</em> is used in the third part of our analysis to examine the
adverse events in both groups. To have a more comprehensive
understanding of functions included in this “bis620.2022” package,
please check the “R” folder for further references regarding each
function.</p>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
